Université de Bordeaux
OptoPath
Cluster of excellence
Presentation of the project OptoPath

A rodent platform entirely dedicated to innovation in experimental psychopathology

OptoPath combines the expertise of neurobiologists, electrophysiologists and experimental psychologists for the identification of new therapeutic targets against 4 major psychological disorders: Addiction, Obesity, PTSD/Anxiety-related disorders and Memory deficits.

Combining innovative animal models and cutting-edge technologies, OptoPath provides :

  • A large range of in vivo assays to evaluate the safety/therapeutic effects of novel drugs in the context of 4 major psychopathologies:

ADDICTION

OBESITY

 PTSD-ANXIETY MEMORY DEFICITS
Headline News OptoPath
An innovative system : Morphing Context for Fear Conditioning without animal handlingAn innovative system : Morphing Context for Fear Conditioning without animal handling

Contextual fear-related studies require moving the rodent from one...

Share on   
[ read more ]
A new publication by Dr Herry's team08/08A new publication by Dr Herry's team
Neuronal coding mechanisms mediating fear behavior
Share on   
[ read more ]
more news
TOP